There are accumulating evidences on the role of dysregulated angiogenesis in Behçet disease. By considering that encouraging results are accumulating about the role of anti–tumor necrosis factor α (TNF-α) agents in the treatment of Behçet disease and that there are evidences of a role of anti-TNF-α agents in angiogenesis inhibition, it is conceivable that antiangiogenic effects of anti-TNF-α agents may contribute to the efficacy of these therapeutic arms in Behçet disease.
Anti-angiogenic effects of anti–tumor necrosis factor α agents in the treatment of behçet disease
Maruotti, Nicola;Corrado, Addolorata;Cantatore, Francesco Paolo
2017-01-01
Abstract
There are accumulating evidences on the role of dysregulated angiogenesis in Behçet disease. By considering that encouraging results are accumulating about the role of anti–tumor necrosis factor α (TNF-α) agents in the treatment of Behçet disease and that there are evidences of a role of anti-TNF-α agents in angiogenesis inhibition, it is conceivable that antiangiogenic effects of anti-TNF-α agents may contribute to the efficacy of these therapeutic arms in Behçet disease.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
